Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Hiroyuki Abe

Concepts (158)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
47
2019
2456
5.940
Why?
Magnetic Resonance Imaging
37
2019
2805
4.790
Why?
Lymphatic Metastasis
11
2017
467
2.680
Why?
Axilla
10
2017
89
2.590
Why?
Ultrasonography, Mammary
7
2013
74
2.360
Why?
Lymph Nodes
7
2017
491
2.230
Why?
Contrast Media
28
2019
969
2.100
Why?
Carcinoma, Ductal, Breast
5
2015
145
1.850
Why?
Image Interpretation, Computer-Assisted
13
2018
649
1.800
Why?
Gadolinium DTPA
13
2015
260
1.570
Why?
Image Enhancement
12
2018
567
1.510
Why?
Carcinoma, Intraductal, Noninfiltrating
4
2017
109
1.440
Why?
ROC Curve
19
2015
743
1.210
Why?
Mammography
8
2018
445
1.100
Why?
Sensitivity and Specificity
23
2017
2002
1.020
Why?
Biopsy
12
2018
1056
0.920
Why?
Radiography, Thoracic
9
2006
395
0.890
Why?
Radiographic Image Interpretation, Computer-Assisted
12
2011
483
0.880
Why?
Middle Aged
44
2019
22369
0.880
Why?
Diagnosis, Computer-Assisted
7
2011
353
0.860
Why?
Aged
34
2019
16013
0.850
Why?
Mass Screening
6
2018
544
0.810
Why?
Diagnosis, Differential
18
2018
1530
0.810
Why?
Retrospective Studies
20
2018
5896
0.810
Why?
Biopsy, Needle
3
2010
262
0.800
Why?
Female
54
2019
38924
0.790
Why?
Adult
35
2019
22734
0.780
Why?
Receptor, erbB-2
2
2015
154
0.750
Why?
Diffusion Magnetic Resonance Imaging
2
2018
203
0.750
Why?
Humans
69
2019
71027
0.660
Why?
Lung Neoplasms
12
2019
1840
0.620
Why?
User-Computer Interface
3
2012
171
0.590
Why?
Breast
7
2018
225
0.590
Why?
Lung Diseases, Interstitial
4
2005
179
0.560
Why?
Ultrasonography, Interventional
2
2013
97
0.560
Why?
Aged, 80 and over
17
2018
5734
0.510
Why?
Diagnostic Imaging
2
2013
411
0.510
Why?
Organometallic Compounds
3
2016
120
0.490
Why?
Neoplasm Staging
8
2018
1780
0.460
Why?
Tomography, Spiral Computed
3
2004
80
0.460
Why?
Carcinoma
1
2013
411
0.450
Why?
Lung Diseases
4
2004
264
0.420
Why?
Decision Making
1
2013
565
0.410
Why?
Solitary Pulmonary Nodule
7
2006
166
0.400
Why?
Ultrasonography
3
2017
644
0.360
Why?
Observer Variation
12
2013
622
0.350
Why?
Reproducibility of Results
12
2018
2386
0.340
Why?
Meglumine
2
2016
36
0.340
Why?
Decision Support Systems, Clinical
2
2018
101
0.330
Why?
Pattern Recognition, Automated
4
2011
229
0.320
Why?
Calcinosis
4
2011
240
0.320
Why?
Area Under Curve
5
2018
325
0.310
Why?
Image Processing, Computer-Assisted
5
2017
1132
0.310
Why?
Sentinel Lymph Node Biopsy
2
2017
54
0.300
Why?
Young Adult
6
2019
4765
0.290
Why?
Imaging, Three-Dimensional
4
2016
524
0.290
Why?
Preoperative Care
2
2016
365
0.280
Why?
Prospective Studies
7
2018
3341
0.260
Why?
Incidental Findings
2
2013
89
0.250
Why?
Kinetics
5
2018
1582
0.250
Why?
Algorithms
8
2017
1731
0.240
Why?
Thrombotic Microangiopathies
1
2019
14
0.230
Why?
Prognosis
3
2013
3170
0.230
Why?
Neoadjuvant Therapy
2
2018
212
0.230
Why?
Fibroadenoma
1
2019
10
0.230
Why?
Tomography, X-Ray Computed
6
2019
2373
0.220
Why?
Radiographic Image Enhancement
4
2009
529
0.210
Why?
Respiratory Distress Syndrome, Adult
1
2019
95
0.210
Why?
Electric Conductivity
1
2018
150
0.210
Why?
Microvessels
1
2018
65
0.210
Why?
Risk Assessment
2
2018
1940
0.210
Why?
Early Detection of Cancer
2
2018
244
0.190
Why?
Computer Simulation
3
2015
950
0.190
Why?
BRCA1 Protein
1
2018
146
0.190
Why?
Carcinoma, Hepatocellular
1
2019
261
0.190
Why?
Artifacts
1
2018
221
0.190
Why?
Clinical Competence
3
2009
620
0.190
Why?
Information Storage and Retrieval
3
2013
124
0.190
Why?
Subtraction Technique
3
2006
155
0.180
Why?
False Negative Reactions
2
2013
69
0.180
Why?
Fourier Analysis
1
2016
135
0.180
Why?
Adipose Tissue
2
2008
221
0.170
Why?
Metabolic Clearance Rate
1
2015
126
0.170
Why?
Liver Neoplasms
1
2019
560
0.160
Why?
Radiography
3
2012
838
0.160
Why?
Genomics
1
2019
491
0.160
Why?
Magnetic Resonance Imaging, Interventional
1
2013
28
0.150
Why?
Radiology Information Systems
1
2013
78
0.150
Why?
Gene Expression Profiling
1
2019
1234
0.140
Why?
Medical Records
1
2013
127
0.140
Why?
Phenotype
2
2019
2016
0.140
Why?
Mastectomy, Segmental
1
2012
73
0.140
Why?
Models, Theoretical
3
2018
449
0.140
Why?
Breast Diseases
2
2011
99
0.140
Why?
Echo-Planar Imaging
2
2017
51
0.130
Why?
Postoperative Period
1
2012
264
0.130
Why?
Neoplasms, Multiple Primary
1
2012
106
0.130
Why?
Predictive Value of Tests
2
2013
1475
0.130
Why?
Illinois
1
2013
390
0.130
Why?
Lymph Node Excision
2
2013
194
0.130
Why?
Lung
5
2019
943
0.130
Why?
Prevalence
2
2013
1041
0.120
Why?
False Positive Reactions
3
2005
226
0.110
Why?
Computer Terminals
1
2009
8
0.110
Why?
Models, Biological
2
2015
1667
0.110
Why?
Adolescent
2
2019
7963
0.110
Why?
Carcinoma, Ductal
1
2008
14
0.110
Why?
Ultrasonography, Doppler, Color
1
2008
37
0.110
Why?
Signal-To-Noise Ratio
2
2019
89
0.100
Why?
Feasibility Studies
3
2017
639
0.100
Why?
Carcinoma, Lobular
1
2008
77
0.100
Why?
Ribs
1
2006
48
0.090
Why?
Radiology
2
2008
174
0.090
Why?
Neoplasm Invasiveness
2
2019
488
0.080
Why?
Risk Factors
2
2014
4596
0.080
Why?
Artificial Intelligence
1
2006
158
0.080
Why?
Radiology, Interventional
1
2004
55
0.070
Why?
Intracranial Aneurysm
1
2004
158
0.070
Why?
Case-Control Studies
2
2004
1609
0.070
Why?
Neoplasm Recurrence, Local
1
2008
1025
0.070
Why?
Magnetic Resonance Angiography
1
2004
208
0.070
Why?
Male
8
2019
36767
0.060
Why?
Pilot Projects
2
2015
690
0.060
Why?
Smoking
1
2003
518
0.060
Why?
Fatal Outcome
1
2019
293
0.050
Why?
Gadolinium
1
2019
94
0.050
Why?
Radiation Dosage
3
2004
210
0.050
Why?
Chemotherapy, Adjuvant
1
2018
438
0.050
Why?
Time
1
2016
72
0.050
Why?
Entropy
1
2015
34
0.040
Why?
Dose-Response Relationship, Drug
1
2019
1986
0.040
Why?
Liver
1
2019
1139
0.040
Why?
Statistics, Nonparametric
1
2015
312
0.040
Why?
Biopsy, Fine-Needle
1
2013
94
0.040
Why?
Receptors, Progesterone
1
2014
158
0.040
Why?
Diagnostic Errors
2
2005
173
0.040
Why?
Software
1
2017
619
0.030
Why?
Fats
1
2011
18
0.030
Why?
Receptors, Estrogen
1
2014
368
0.030
Why?
Apoptosis
1
2019
1665
0.030
Why?
Adenocarcinoma
3
2004
1144
0.030
Why?
Injections
1
2010
104
0.030
Why?
Analysis of Variance
1
2012
934
0.030
Why?
Biological Transport
1
2010
403
0.030
Why?
Liquid Crystals
1
2009
6
0.030
Why?
Genetic Predisposition to Disease
1
2018
1955
0.030
Why?
Confidence Intervals
1
2009
228
0.030
Why?
Mutation
1
2018
3376
0.020
Why?
Treatment Outcome
1
2018
6657
0.020
Why?
Cluster Analysis
1
2006
351
0.020
Why?
Hyperplasia
1
2004
147
0.020
Why?
Carcinoma, Small Cell
1
2004
140
0.020
Why?
Quality Control
1
2003
114
0.020
Why?
Japan
1
2003
282
0.020
Why?
Incidence
1
2003
1423
0.010
Why?
Time Factors
1
2008
5024
0.010
Why?
Carcinoma, Squamous Cell
1
2004
991
0.010
Why?
Follow-Up Studies
1
2004
3419
0.010
Why?
Abe's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_